I'm sorry I don't agree with you about the price remaining low. The struggle a transgenics company has to go through to survive is like Navy Seal training. All of you who bash the management have no idea how good these guys are and the great moves they have made. Just because most of BP is blind to the future does not mean the future will not come. GTCB stands poised for success with an approved product in Europe and an about to be approved product in the USA. Whether or not they get a BP to go forward with them on Atryn (chances of it happening are still greater than it not happening) does not matter. They will get someone to go with them and they will get enough money to continue. Dilution at this level is not in the cards. LFB is not going to disappear and the fact they are embarking on a new enterprise (Fix) with GTCB shows they have more faith than those of you throwing your stock away at 80cents a share.
What the government will or wont do is pure speculation. Health care is moving over the 25% of total cost level and rising like Katrina. Its been 60+ years since the Kefauver congressional investigation of the "drug companies". There maybe at least one smart young congressman in DC with a little knowledge of history who will realise how much good he might do himself by kicking off a re-run. People are beginning to listen when you bring up medical costs.